Showing results (1591-1600 of 2,635) with videos related to

Sort By:
Pageof 264
Obstetrics and Gynecology|March 4, 2008
Noncomparative contraceptive efficacy of cellulose sulfate gelChristine K Mauck, Ron G Freziers, Terri L Walsh, et al.
Oral Oncology|January 23, 2016
Comparative effectiveness of induction chemotherapy for oropharyngeal squamous cell carcinoma: A population-based analysisDavid J Sher, David L Schwartz, Lucien Nedzi, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|November 29, 2023
Variability in changes in physician outpatient antibiotic prescribing from 2019 to 2021 during the COVID-19 pandemic in Ontario, CanadaPranav Tandon, Kevin A Brown, Nick Daneman, et al.
Clinical Neuropharmacology|August 5, 2003
Adjuvant topiramate administration: a pharmacologic strategy for addressing NMDA receptor hypofunction in schizophreniaStephen I Deutsch, Barbara L Schwartz, Richard B Rosse, et al.
Collaborations (Coral Gables, Fla.)|February 22, 2021
Development of a culturally relevant physical activity intervention for Navajo cancer survivorsHendrik D de Heer, Jennifer Bea, Brian Kinslow, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 1998
Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathwayS Gross-Mesilaty, E Reinstein, B Bercovich, et al.
Frontiers in Neuroscience|November 7, 2022
Perivascular spaces as a marker of disease severity and neurodegeneration in patients with behavioral variant frontotemporal dementiaJasmine Moses, Benjamin Sinclair, Daniel L Schwartz, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Pharmacokinetic interactions of zidovudine and methadone in intravenous drug-using patients with HIV infectionE L Schwartz, A B Brechbühl, P Kahl, et al.
The Biochemical Journal|November 14, 1997
Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitorA E Mast, D A Higuchi, Z F Huang, et al.
Pageof 264